Published in Med Devices (Auckl) on March 16, 2009
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg (2008) 4.86
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg (1996) 4.41
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet (2003) 3.89
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology (2001) 3.85
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet (1994) 3.38
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol (2007) 3.15
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol (1992) 2.86
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg (1987) 2.54
Expanding criteria for resectability of colorectal liver metastases. Oncologist (2008) 2.39
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol (2001) 2.20
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10
Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol (1993) 2.09
Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg (1990) 1.99
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst (1996) 1.93
Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery (1993) 1.79
Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol (2007) 1.60
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 1.52
Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology (2000) 1.43
Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut (2006) 1.42
Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg (2007) 1.35
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg (1990) 1.34
Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg (1997) 1.29
Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery (2002) 1.29
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol (1989) 1.28
Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol (2007) 1.22
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol (2007) 1.21
Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol (1983) 1.21
Surgical therapy of hepatic colorectal metastasis. Semin Oncol (1999) 1.15
A technique for the use of cryosurgery to assist hepatic resection. J Am Coll Surg (1995) 1.13
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg (2005) 1.11
Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer (1984) 1.10
Arterial therapy of hepatic colorectal metastases. Br J Surg (1996) 1.10
Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol (1994) 1.10
Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer (1979) 1.09
A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol (1990) 1.08
Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial. Cancer (1994) 1.06
Treatment of liver metastases of colorectal cancer. Ann Oncol (2005) 1.04
Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin. Ann Surg Oncol (2007) 1.02
Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. Ann R Coll Surg Engl (2001) 1.00
Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg (1998) 0.99
Current role of radiofrequency ablation for the treatment of colorectal liver metastases. Br J Surg (2006) 0.99
Complications of long term transbrachial hepatic arterial infusion chemotherapy. AJR Am J Roentgenol (1977) 0.97
Systemic therapy for metastatic colorectal cancer: current questions. Cancer (2008) 0.97
Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol (1999) 0.96
Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis. Ann Surg (2000) 0.95
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol (1985) 0.94
Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer. Cancer Chemother Pharmacol (1997) 0.93
Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study. Cancer (1992) 0.93
Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer (2000) 0.93
Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol (1997) 0.92
Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. Surg Oncol (2002) 0.90
Percutaneously implantable catheter-port system: preliminary technical results. Radiology (1997) 0.89
Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg (1983) 0.89
Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol (2006) 0.89
Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil. J Clin Oncol (1995) 0.87
Percutaneous implantation of hepatic artery infusion reservoir by sonographically guided left subclavian artery puncture. AJR Am J Roentgenol (1996) 0.87
Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery. Ann Surg (2007) 0.87
Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy. Br J Surg (2006) 0.87
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases. J Surg Oncol (2008) 0.86
Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. Hepatogastroenterology (2002) 0.85
Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases. Br J Surg (1999) 0.85
Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. World J Gastroenterol (2002) 0.85
Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases. Am J Clin Oncol (2001) 0.85
Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit. AJR Am J Roentgenol (2008) 0.84
Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients. J Clin Oncol (1997) 0.84
Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases. Eur J Surg Oncol (2006) 0.84
[Implantable catheter systems. Experience with 205 patients]. Dtsch Med Wochenschr (1989) 0.83
Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer. J Natl Cancer Inst (1997) 0.83
Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases. Br J Cancer (2001) 0.83
Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Surgery (2003) 0.82
Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patients. Ann Oncol (2000) 0.81
The surgical aspects of the totally implantable hepatic artery infusion pump. Arch Surg (2001) 0.81
Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging (2007) 0.81
Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol (2005) 0.81
Intraportal chemotherapy for colorectal hepatic metastases. World J Surg (1995) 0.81
Adrenal angiosarcoma: report of a case. Surg Today (2002) 0.91
Embolisation of arteriovenous intrahepatic fistulas associated with diffuse haemangiomatosis of the liver. Report of a case in an adult and review of the literature. Chir Ital (2007) 0.84
The length of peritoneal surgical manipulation correlates with serum CA 125 levels. In Vivo (2011) 0.77
Potential advantages of loco-regional intra-arterial chemotherapy. In Vivo (2007) 0.75
Adrenal incidentalomas: indications for surgery. Chir Ital (2003) 0.75